Barclays
ARTC

Barclays’s ARTHROCARE CORP ARTC Stock Holding History

Barclays’s Portfolio ARTC Stock Details ARTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-358,784
Closed -$17.2M – 8055
2014
Q1 		$17.2M Buy
358,784
+332,823
+1,282% +$15.8M 0.02% 783
2013
Q4 		$1.04M Buy
25,961
+13,114
+102% +$486K ﹤0.01% 3358
2013
Q3 		$450K Buy
12,847
+7,444
+138% +$260K ﹤0.01% 4232
2013
Q2 		$187K Buy
+5,403
New +$186K ﹤0.01% 5243

Barclays's ARTC Position: Q2 2014 in Review

Barclays sold out of ARTHROCARE CORP (ARTC) in Q2 2014, closing a stake of 358,784 shares — an estimated $17.2M sold.

Barclays first reported a position in ARTC in Q2 2013 and held it in 4 quarters. The position peaked at $17.2M in Q1 2014. 0 funds tracked by Wall St. Rank hold ARTC as of Q2 2014.

  • Barclays reported no remaining ARTHROCARE CORP position as of Q2 2014 after selling out during the quarter.
  • Barclays sold 358,784 ARTHROCARE CORP shares in Q2 2014, an estimated $17.2M.
  • Barclays first reported a position in ARTHROCARE CORP in Q2 2013 and held it in 4 quarters.
  • Barclays's ARTHROCARE CORP position peaked at $17.2M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held ARTHROCARE CORP as of Q2 2014.

Based on Barclays's 13F filing for Q2 2014, filed 14 Aug 2014.